Article
Enhanced bacterial cancer therapy delivering therapeutic RNA interference of c-Myc, a key driver of tumourigenesis.
2023-09-01
Abstract excerpt
<title>Abstract</title> <p><bold>BACKGROUND</bold>: Bacterial cancer therapy was first trialled in patients at the end of the nineteenth century. More recently, tumour-targeting bacteria have been harnessed to deliver plasmid-expressed therapeutic interfering RNA to a range of solid tumours. A major limitation to clinical translation of this is the short-term nature of RNA interference in vivo due to plasmid inst...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e690894-f617-59c4-af93-5f22eec7bcd6
- DOI
- 10.21203/rs.3.rs-3262697/v1
